Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspective of patients with autoimmune diseases on COVID-19 vaccination
Laura Boekel, Femke Hooijberg, Zoé L.E. van Kempen, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 4, pp. e241-e243
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS–CoV‐2 Vaccination
Peter Izmirly, Mimi Kim, Marie I. Samanovic, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 2, pp. 284-294
Open Access | Times Cited: 130
Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series
Leon D. Kaulen, Sofia Doubrovinskaia, Christoph Mooshage, et al.
European Journal of Neurology (2021) Vol. 29, Iss. 2, pp. 555-563
Open Access | Times Cited: 119
COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey
Priyanka Gaur, Hardik Agrawat, Anuj Shukla
Rheumatology International (2021) Vol. 41, Iss. 9, pp. 1601-1605
Open Access | Times Cited: 81
Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
Laura Boekel, Laura Kummer, Koos P J van Dam, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 8, pp. e542-e545
Open Access | Times Cited: 76
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
Laura Boekel, Eileen W Stalman, Luuk Wieske, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e417-e429
Open Access | Times Cited: 50
The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
Yan Xie, Yang Liu, Yi Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
It is time to improve the acceptance of COVID‐19 vaccines among people with chronic diseases: A systematic review and meta‐analysis
Yang Zhao, Juan Du, Zhen Li, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 21
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
Е. Л. Насонов, А. М. Лила, Mazurov Vi, et al.
Rheumatology Science and Practice (2021) Vol. 59, Iss. 3, pp. 239-254
Open Access | Times Cited: 50
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
Ernesto Zavala-Flores, Jannin Salcedo-Matienzo, Ana Quiroz-Alva, et al.
Clinical Rheumatology (2021) Vol. 41, Iss. 5, pp. 1349-1357
Open Access | Times Cited: 47
COVID‐19 vaccination in patients with rheumatic diseases: Vaccination rates, patient perspectives, and side effects
Yan Kiu Li, Michael Pak Kiu Lui, Lip Long Yam, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 33
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study
Parikshit Sen, R Naveen, Arvind Nune, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 1, pp. 65-76
Open Access | Times Cited: 28
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Journal of Autoimmunity (2023) Vol. 135, pp. 102984-102984
Open Access | Times Cited: 18
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
Parikshit Sen, R Naveen, Nazanin Houshmand, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 10, pp. 3291-3301
Open Access | Times Cited: 17
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus
Kavita Y. Sarin, Hong Zheng, Yashaar Chaichian, et al.
JCI Insight (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 5
Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology
Sonja Hochmeister, Martin Rakuša, Elena Moro, et al.
Neurological Sciences (2025)
Open Access
The Use of COVID-19 Vaccines in Patients with SLE
Wei Tang, Yevgeniya Gartshteyn, Edd Ricker, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 11
Open Access | Times Cited: 39
Cutaneous vasculitis following COVID-19 vaccination
Giulio Cavalli, Serena Colafrancesco, Giacomo De Luca, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 11, pp. e743-e744
Open Access | Times Cited: 38
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
Teny Grace Skaria, Anu Sreeprakash, Rashwith Umesh, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 11, pp. e755-e764
Open Access | Times Cited: 22
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases
Renaud Felten, Maxime Dubois, Manuel F. Ugarte‐Gil, et al.
Lara D. Veeken (2021) Vol. 60, Iss. SI, pp. SI68-SI76
Open Access | Times Cited: 28
Vaccine hesitancy among people with multiple sclerosis
Siew Mei Yap, Mahmood Al Hinai, Maria Gaughan, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 56, pp. 103236-103236
Open Access | Times Cited: 28
Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases
Rodrigo Poubel Vieira de Rezende, Alessandra Sousa Braz, Maria Fernanda Brandão de Resende Guimarães, et al.
Vaccine (2021) Vol. 39, Iss. 44, pp. 6454-6459
Open Access | Times Cited: 27
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
Samantha Epstein, Zongqi Xia, Annie Lee, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 57, pp. 103433-103433
Open Access | Times Cited: 27
COVID-19 vaccine literacy in patients with systemic autoimmune diseases
María Correa‐Rodríguez, Blanca Rueda‐Medina, José Luis Callejas‐Rubio, et al.
Current Psychology (2022) Vol. 42, Iss. 16, pp. 13769-13784
Open Access | Times Cited: 21
HLA‐dependent variation in SARS‐CoV‐2 CD8 + T cell cross‐reactivity with human coronaviruses
Paul Buckley, Chloe H. Lee, Mariana Pereira Pinho, et al.
Immunology (2022) Vol. 166, Iss. 1, pp. 78-103
Open Access | Times Cited: 20
Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study
Jessica Gordon, Kimberly Showalter, Yin Wu, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 4, pp. e243-e246
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top